AiM Medical Robotics
Generated 5/11/2026
Executive Summary
AiM Medical Robotics is a pre-clinical stage neurosurgical robotics company developing a portable, MRI-compatible surgical robot designed for use in both the MRI suite and the operating room. The company's technology addresses critical challenges in functional brain disorders and brain cancer surgery by enabling high-precision, automated procedures within the MRI environment, reducing procedure times and hospital costs. Founded in 2018 and headquartered in Waltham, MA, the company is positioning itself to compete in the growing market for MRI-guided interventions, which offer superior soft tissue visualization and real-time feedback during surgery. However, the company remains in early development with no disclosed funding rounds or regulatory milestones, suggesting significant capital requirements and execution risk ahead.
Upcoming Catalysts (preview)
- Q3 2026First-in-human clinical trial initiation35% success
- Q4 2026FDA IDE approval for investigational device exemption40% success
- Q2 2026Series A funding round or strategic partnership50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)